Incontinence-associated Dermatitis
Conditions
Brief summary
The aim of this explorative study is to collect information about biomarkers that differentiate skin affected by Incontinence Associated Dermatitis (IAD) from non-affected skin.
Detailed description
The findings obtained from this study will be used to develop biosensors that aims to predict the increasing risk of developing IAD and hence be able to prevent the occurrence of IAD.
Interventions
None listed
Sponsors
Essity Hygiene and Health AB
Study design
Observational model
CASE_ONLY
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years. 2. Mentally and physically able to participate in this study. 3. Willing and able to provide written informed consent to participate in this study or, if unable to provide such consent, have a legal representative who is willing and able to provide informed consent on behalf of the participant. 4. Individual with urinary and/or faecal incontinence and using incontinence products at a regular basis. 5. Has an area under incontinence products with IAD, incontinence associated dermatitis that shows any sign(s) of skin irritation e.g., redness, itching, rashes. 1A and 2A according to GLOBIAD categorisation model \[Appendix C for detailed description\]. 1A is persistent redness without clinical sign of infection and 2A is skin loss without clinical sign of infection.
Exclusion criteria
1. Severe skin breakdown at the investigated area. 2. Individual with skin infection at the investigated area. 3. GLOBIAD 1B and 2B, 1B is persistent redness with clinical signs of infection and 2B is skin loss with clinical sign of infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identified biomarkers level | One time |
Countries
Sweden
Outcome results
None listed